In the present study we have used cell culture assays in order to assess the damage in the haematopoietic system 1 year after peripheral blood stem cell transplantation (PBSCT), and to establish at what level, haematopoietic progenitor cells (HPC) or stroma, this damage occurs. Thirty-one patients, nine breast cancer (BC), 17 nonHodgkin lymphoma (NHL) and five Hodgkin disease (HD), who had received autologous PBSCT were included. Forty-eight normal subjects who had given informed consent were used as controls. Results were also compared with a matched group of patients (25 cases) prior to PBSCT. Progenitor cells were analysed using CFU-GM and plastic adherent delta (P⌬) assays. Long-term bone marrow cultures (LTBMC) in one and two stages were established. One year after transplant both the number of committed progenitor cells and the CFU-GM production in LTBMC were significantly reduced in the three groups of patients when compared with controls (P Ͻ 0.05 or P Ͻ 0.01). Two-stage LTBMC experiments showed that the impairment in CFU-GM production was due to damage in both patients' stroma and haematopoietic progenitor cells (HPC). All patients, except those with HD, showed a decreased stromal layer confluence (P Ͻ 0.05), with significant differences in cell composition as compared to normal bone marrow (P = 0.001). When all these variables were compared with pretransplant results, we observed that stroma formation was significantly lower after PBSCT (P Ͻ 0.05), while the number of progenitor cells analysed by the P⌬ assay was significantly increased (P Ͻ 0.05). We can conclude that even 1 year after PBSCT, both the committed HPC and BM stroma remain damaged. Keywords: haematopoietic damage; clonogenic assays; long-term bone marrow cultures; plastic delta assays Recently, there has been a shift from bone marrow to peripheral blood as the source of haematopoietic progenitor cells (HPC) for transplantation. 1 This shift has been due to the observation that peripheral blood stem cells (PBSC)
lead to faster engraftment which results in lower morbidity. 2 Although, PBSC are apparently as effective as BM stem cells in establishing sustained long-term multilineage haematopoiesis, basic studies using appropriate culture techniques to evaluate the functional activity of haematopoiesis are scanty.
In patients transplanted with autologous bone marrow it has been reported that there is damage in both haematopoietic progenitors and bone marrow (BM) stroma. 3 Long-term bone marrow cultures (LTBMC) are employed as an in vitro model for in vivo haematopoiesis. Accordingly, this approach may be of value for the study of both primitive haematopoietic stem cells and bone marrow microenvironment. 4, 5 In addition, clonogenic and plastic delta (P⌬) assays would allow the study of committed and primitive HPC. 6, 7 In the present study we have used three types of cell culture assays (LTBMC, P⌬ and clonogenic assays) in order to assess the damage in the haematopoietic system 1 year after PBSCT, and to establish at what level (HPC or stroma) the damage occurs.
Materials and methods

Patients
Thirty-one patients, nine breast cancer (BC), 17 non-Hodgkin lymphoma (NHL) and five Hodgkin disease (HD), who received PBSCT were included in the study. Median age was 41 years and male/female ratio was 15/16. Chemotherapy regimens before PBSCT included CAF or super-CAF (cyclophosphamide + adriamicin + 5FU) for BC patients, CHOP or VECOP-B for NHL and MOPP/ABV or ABVD for HD as first-line chemotherapy. When patients with lymphoma (HD and NHL) did not reach a complete remission or a good partial remission, salvage therapy with mini-BEAM (BCNU 60 mg/m /l granulocytes and 20 × 10 9 /l platelets in a median of 11 (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) ) and 13 (7-28) days, respectively.
Control group
Forty-eight normal subjects who gave informed consent were used as controls. Thirty-four were patients who underwent orthopaedic or plastic surgery and 14 were normal donors for allogeneic BMT. Median age was 35 years (18-60) and male/female ratio was 33/15.
The 1 year post-transplant results were also compared with the pretransplant data obtained in a group of 25 patients (10 BC, nine NHL and six HD) matched for age and sex and previous chemotherapy.
Methods
Marrow processing: In the 31 patients the bone marrow samples were obtained 1 year after transplantation and were processed in identical conditions to control BM samples. They were obtained from the posterior iliac crest or sternal puncture after informed consent was obtained.
For clonogenic CFU-GM and P⌬ assays mononuclear cells (MNC) were separated by centrifugation on a FicollHypaque gradient (Lymphoprep TM, Niergaard, Oslo, Norway) (d = 1.077 g/ml). Interface cells were washed and resuspended on IMDM supplemented with FCS. For LTC, cells were obtained by gravity sedimentation using a solution of 0.1% methylcellulose. The cells remaining in suspension were washed with IMDM-FCS. 8 Clonogenic assays: CFU-GM were cultured as previously described. 9 Briefly, 2 × 10 5 mononuclear cells/ml in Iscove's modified Dulbecco's medium (IMDM) (Gibco, Grand Island, NY, USA) were plated on 35-mm Petri dishes in 0.9% methylcellulose containing 10% PHA-leucocyte conditioned medium, 10% bovine serum albumin and 10% human AB serum. Cultures were incubated at 37°C in a fully humidified atmosphere with 5% CO 2 and scored at day 14 under an inverted microscope. Colonies were scored as aggregates with more than 40 cells; aggregates of between four and 40 cells were scored as clusters.
Delta assay of plastic adherent progenitor cells:
Delta assay of plastic adherent progenitor cells (P⌬) was performed according to Gordon's method 7 in seven cases 1 year post-PBSCT, seven healthy controls and 12 patients before transplantation. 1 ϫ 10 7 MNC were placed in 25-cm 2 plastic tissue culture flasks (Falcon, Becton Dickinson, Franklin Lakes, NJ, USA) and incubated for 2 h. The non-adherent cells were removed. Adherent cells were incubated for a further 7 days in IMDM with 10% FCS and HS (BioWhittaker, Walkersville, MD, USA) and 2 × 10 −6 m methyl-prednisolone (Sigma Immunochemicals, St Louis, MO, USA). Haematopoietic growth factors were not added. Afterwards non-adherent cells were pelleted and assayed for CFU-GM. The score of these cultures was performed after 14 and 21 days of incubation. Results were expressed by the total number of CFU-GM obtained after clonogenic assays.
Long-term BM cultures: LTBMC were established according to the method of Gartner and Kaplan with slight modificatons. 8 Briefly, 2 × 10 6 cells/ml (10 × 10 6 total cells) were innoculated in tissue culture flasks (Falcon) in LTBMC medium IMDM 350 mOsm/kg supplemented with 10% pre-selected FCS10% horse serum (HS) (BioWhittaker), and 5 × 10 −7 m hydrocortisone sodium succinate (Sigma). The cultures were incubated in a humidified atmosphere with 5% CO 2 in air at 33°C for 5 weeks. At weekly intervals before re-feeding, the stromal layer formation was studied under an inverted microscope. The degree of confluence, the presence of adipocytes and cobblestone areas of haemopoiesis were assessed and four stromal layer subtypes were established: (1) with all cellular components; (2) without adipocytes; (3) without adipocytes and cobblestone areas; and (4) without stromal layer formation. For re-feeding, half of the supernatant was removed and replaced with fresh LTBMC medium. The non-adherent cells harvested were counted and assayed for their CFU-GM content. After 5 weeks of culture, the total supernatant was removed and the adherent layer was detached by exposure to trypsin. Cells were recovered, washed, counted and assayed for their CFU-GM content.
Two-stage-LTBMC:
When stromal layers were established in LTBMC, control or patient layers with at least 40% of flask surface covered were irradiated with 15 Gy in a Cobalt bomb (Theratron 780). A second innoculum to obtain haematopoiesis was constituted by patient or control MNC. 8 CFU-GM were evaluated during 5 weeks as for LTBMC in one stage.
Statistical analysis
Statistical analysis was carried out with the SPSSG.1 program for PowerMac. The following non-parametric tests were used: Mann-Whitney's U test for unpaired data, Wilcoxon's t test for paired data and Pearson or Spearman test for quantitative correlation and stepwise for multiple correlation. Tables 1 and 2 show the results of clonal and LTBMC carried out 1 year after transplantation. The number of committed progenitor cells was significantly reduced in all patient groups when compared with controls (P Ͻ 0.05 and P Ͻ 0.01) ( Table 1) . When LTBMC were analysed, we observed that from week 1 to week 5 of culture the CFU-GM production decreased (Figure 1 ) leading to a reduced number of CFU-GM produced by LTBMC from all groups of patients (P Ͻ 0.05 or P Ͻ 0.01) ( Table 1) . Patients also showed a decreased stromal layer confluence (P Ͻ 0.05) except in patients with HD.
Results
When post-PBSCT results were compared with those obtained in the matched group of patients previous to transplantation, we could observe that 1 year after PBSCT both committed granulomacrophagic progenitors and CFU-GM produced in LTBMC were reduced, but without statistical significance. By contrast, significant differences were observed in the stromal layer confluence that was reduced 1 year post-transplant (P Ͻ 0.05) ( Table 3) .
P⌬ assays showed that 1 year post-transplant, the number of progenitors assessed was higher than those of controls, but a statistically significant difference was only reached in HD (P Ͻ 0.05) ( Table 2) . Moreover, a similar situation was observed, upon comparison with the pretransplant group (the number of P⌬ progenitors was higher 1 year after PBSCT (P Ͻ 0.05)) ( Table 3) . Two-stage LTBMC showed that transplanted patients displayed lower CFU-GM production than controls both when patient HPC or, in particular, stroma was used (P = 0.03) (Table 4) . Moreover, a lower degree of confluence in the stromal layer was associated with a decrease in the CFU-GM production (r = 0.6; P Ͻ 0.05). However, when patient stromal layer was compared with patient HPC no significant differences were observed (Table 4) .
Weekly microscopic examination showed that patient stromal layer was often qualitatively different from that of the controls, some patients showing no adipocytes or no cobblestone areas with a significant difference in cell composition compared with normal bone marrow (P = 0.002) (Figure 2 ). When the individual patient groups were con-904 Table 4 Two-stage long-term bone marrow cultures
CFU-GM produced throughout the LTBMC period
Patients Controls P
HPC analysis
Results expressed as mean ± s.d. CFU-GM produced when plating 5 × 10 6 cells as second inoculum. Stroma analysis: cultures performed with stroma from patients. HPC analysis: cultures performed with haematopoietic progenitor cells from patients. Controls: stroma and HPC from normal subjects. Upon comparing patients' stroma with patients' HPC no significant differences were observed (P = 0.5). sidered, these differences were seen in BC patients (P = 0.0014) and NHL (P = 0.0005) but not in the HD group (P = 0.47) (Figure 2 ).
Discussion
The stem cell transplantation procedure can damage the haematopoietic system due to the conditioning regimens, apheresis process, cryopreservation and thawing of HPC, etc. The present study aimed to analyse the nature of the damage in the late post-transplant period (1 year after the procedure) in patients who had received autologous PBSC. We observed that post-PBSCT, both haematopoietic progenitor cells and stromal layer formation were reduced in comparison to normal bone marrow. These results obtained with PBSCT are similar to those reported by Domenech et al 3 upon analysing BM transplants. However, in the present study when different patient subgroups were screened, it was found that in patients with HD, only haematopoietic progenitor cells were significantly affected.
Soligo et al 10 have recently reported on a decreased number of LTC-IC immature progenitors after haematopoietic stem cell transplantation and Podestá et al 11 showed a similar feature in patients after allogeneic transplantation. Our results using two-stage LTBMC are similar to those observed by these authors. However, upon using the P⌬ assay, we observed that in some cases these progenitors were increased in comparison with controls. It has been claimed that progenitors that adhere to plastic could be more immature than those that adhere to stroma and that they are capable of sustaining haematopoiesis in vitro. 7, 12 The discrepant results between LTBMC and P⌬ assays could reflect that the two assays identify different cell populations. 12 Moreover, since the P⌬ assay is a stroma-free system the favourable cell growth observed in this system suggests that immature HPC are well preserved 1 year after transplant and impairment in haematopoiesis is mainly due to marrow stroma.
When data after transplantation were compared with those obtained from a similar group of patients who had received conventional chemotherapy but who were analysed before PBSCT, we could observe that all the haematopoietic parameters had decreased, but only stromal layer formation was significantly damaged by the transplantation process. These data show that the transplantation procedure increases the damage already caused by chemotherapy with a particular influence on the stromal layer.
When a morphological study of the stroma was performed, it was apparent that patient stromal layers were qualitatively different from controls, with the NHL patients showing the most pathology. It has been shown that a functional stromal layer must display all cell components (adipocytes, cobblestone areas, etc). 13 The absence of these cells in our patients indicates clearly a damaged bone marrow microenvironment after PBSCT. These results concur with those of Soligo et al 10 who used a different approach, analysing CFU-F in order to assess stromal damage.
The present results suggest that 1 year after PBSCT, the stromal damage is even more evident than damage of the HPC. This fact has been previously shown in murine models.
14 It has been claimed that because stromal cells have less mitotic activity they also have a reduced repair capacity. The most primitive HPC can be increased as a compensatory mechanism to maintain a sufficient number of haematopoietic cells on a defective BM stroma.
In summary, we can conclude that after PBSCT, haematopoiesis is damaged over a long period of time due to damage both in HPC and the stroma. However, this damage is not the same in all patient groups and is more pronounced in the BM microenvironment.
